ALBPS.PA
Price:
$0.3184
Market Cap:
$2.27M
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical stu...[Read more]
Industry
Biotechnology
IPO Date
2015-07-13
Stock Exchange
EURONEXT
Ticker
ALBPS.PA
According to Biophytis S.A.’s latest financial reports and current stock price. The company's current ROE is 294.01%. This represents a change of 255.93% compared to the average of 82.60% of the last 4 quarters.
The mean historical ROE of Biophytis S.A. over the last ten years is 66.04%. The current 294.01% ROE has changed 345.21% with respect to the historical average. Over the past ten years (40 quarters), ALBPS.PA's ROE was at its highest in in the September 2022 quarter at 314.48%. The ROE was at its lowest in in the September 2020 quarter at -257.02%.
Average
66.04%
Median
-49.25%
Minimum
-543.19%
Maximum
1.29%
Discovering the peaks and valleys of Biophytis S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 290.91%
Maximum Annual ROE = 1.29%
Minimum Annual Increase = -337.26%
Minimum Annual ROE = -543.19%
Year | ROE | Change |
---|---|---|
2023 | 441.43% | -65.75% |
2022 | 1.29% | -337.26% |
2021 | -543.19% | 46.10% |
2020 | -371.81% | -247.09% |
2019 | 252.78% | -227.18% |
2018 | -198.76% | 269.67% |
2017 | -53.77% | -69.25% |
2016 | -174.85% | 290.91% |
2015 | -44.73% | -169.33% |
2014 | 64.52% | -52.97% |
The current ROE of Biophytis S.A. (ALBPS.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
395.67%
5-year avg
213.60%
10-year avg
66.04%
Biophytis S.A.’s ROE is greater than Novacyt S.A. (-25.50%), greater than Hybrigenics SA (-679.52%), greater than Biosynex SA (-29.48%), greater than Neovacs S.A. (-123.46%), less than Quantum Genomics Société Anonyme (1.40%),
Company | ROE | Market cap |
---|---|---|
-25.50% | $39.97M | |
-679.52% | $3.95M | |
-29.48% | $18.40M | |
-123.46% | $446.08K | |
1.40% | $5.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biophytis S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biophytis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biophytis S.A.'s ROE?
How is the ROE calculated for Biophytis S.A. (ALBPS.PA)?
What is the highest ROE for Biophytis S.A. (ALBPS.PA)?
What is the 3-year average ROE for Biophytis S.A. (ALBPS.PA)?
What is the 5-year average ROE for Biophytis S.A. (ALBPS.PA)?
How does the current ROE for Biophytis S.A. (ALBPS.PA) compare to its historical average?